comparemela.com

Latest Breaking News On - Gastrointestinal cancer research program - Page 3 : comparemela.com

Metastatic Colorectal Cancer Treatment Boosts Survival

Metastatic Colorectal Cancer Treatment Boosts Survival
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Research on Novel Targets and Potential Risk Factors Drives Improvements in the Management of GI Cancers

Gastrointestinal oncology experts discuss current strategies and novel developments in gastrointestinal cancers, the role of intestinal dysbiosis and gastrointestinal carcinogenesis, germline genetic features in appendiceal cancer, and the need for anticipatory, multidisciplinary guidance in clinical practice.

Vanderbilt mourns loss of surgical leader Beauchamp

R. Daniel Beauchamp, MD, former chair of the Section of Surgical Sciences at Vanderbilt University Medical Center and surgeon-in-chief of Vanderbilt University Hospital, died Nov. 27 at Alive Hospice. He was 66 years old.

Patients had significant and clinically meaningful improvement for survival in colorectal cancer trial

Patients had significant and clinically meaningful improvement for survival in colorectal cancer trial
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of Fruquintinib in Refractory Metastatic Colorectal Cancer from the Upcoming ESMO 2022 Presentation

HUTCHMED Highlights Phase III FRESCO-2 MRCT Data Summary of Fruquintinib in Refractory Metastatic Colorectal Cancer from the Upcoming ESMO 2022 Presentation
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.